Identify a common signature to SAID enabling rapid differential diagnosis
Provide deep characterization of each specific pathogenic pathway and build dedicated analysis kits
Build a robust algorithm enabling reliable triage among the whole SAID spectrum
12 Countries |
16 M€ Funding |
|
6.5 |
25 Partners |
37 Hospitals |